Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study

@article{Hong2016EfficacyAS,
  title={Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study},
  author={Zhen Hong and Yushi Inoue and Wei-Ping Liao and Hong-mei Meng and on behalf of the EP0008 Study Group},
  journal={Epilepsy Research},
  year={2016},
  volume={127},
  pages={267-275}
}
  • Zhen Hong, Yushi Inoue, +2 authors on behalf of the EP0008 Study Group
  • Published in Epilepsy Research 2016
  • Medicine
  • OBJECTIVE To evaluate the efficacy and safety of adjunctive lacosamide treatment in Chinese and Japanese adults with uncontrolled focal (partial-onset) seizures (POS), with or without secondary generalization. METHODS A 24-week, randomized, double-blind, placebo-controlled study (EP0008; NCT01710657) was conducted in patients (aged 16-70 years) with uncontrolled POS and taking 1-3 concomitant antiepileptic drugs from 72 sites across China and Japan. Following an 8-week Baseline period… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Figures, Tables, and Topics from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 20 REFERENCES

    Examining the Clinical Utility of Lacosamide

    VIEW 10 EXCERPTS
    HIGHLY INFLUENTIAL

    Safety, tolerability and pharmacokinetics of the novel antiepileptic drug lacosamide in Asian populations: comparison of healthy Japanese and Chinese subjects following single oral administration

    • T. kagaki, S. Watanabe, T. Kumke
    • Jpn. Pharmacol. Ther
    • 2015

    Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years

    • W. osenfeld, N. B. Fountain, +5 authors S. S. Investigators
    • Epilepsy Behav
    • 2014